Steven Cohen Assembly Biosciences, Inc. Transaction History

Point72 Asset Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$12.9 - $20.8 $1.29 Million - $2.08 Million	-100,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$17.7 - $24.93 $1.77 Million - $2.49 Million	100,000 New	100,000 $1.97 Million
Q4 2018 Feb 14, 2019	SELL	$19.05 - $36.45 $208,788 - $399,492	-10,960 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$34.41 - $44.23 $377,133 - $484,760	10,960 New	10,960 $407,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.